Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 15, Number 2—February 2009
Dispatch

Effect of Free Treatment and Surveillance on HIV-Infected Persons Who Have Tuberculosis, Taiwan, 1993–2006

Shu-Hui Tseng, Donald Dah-Shyong Jiang, Hao-Seong Hoi, Hsiu-Yun Lo, and Kao-Pin HwangComments to Author 
Author affiliations: Centers for Disease Control Department of Health, Taipei, Taiwan (S.-H. Tseng, D.D.-S. Jiang, H.-S. Hoi, H.-Y. Lo); Chang Gung University College of Medicine, Kaohsiung, Taiwan (S.-H. Tseng); Chang Gung Memorial Hospital—Kaohsiung Medical Center, Kaohsiung, Taiwan (K.-P. Hwang)

Main Article

Table 1

Demographic and clinical characteristics of 660 persons coinfected with HIV and TB, Taiwan, 1993–2006*

Characteristics No. (%) persons p value†
Sex <0.0001
M 612 (92.7)
F
 48 (7.3)
Age, y <0.0001
<45 498 (75.5)
>45
 162 (24.5)
Sputum smear (n = 484) <0.0001
Negative 287 (59.3)
Positive
 197 (40.7)
Sputum culture (n = 340) 0.0172
Negative 148 (43.5)
Positive
 192 (56.5)
Pulmonary radiograph results (n = 531) <0.0001
Normal 54 (10.2)
Abnormal
 477 (89.8)
Extrapulmonary TB‡ <0.0001
Yes 73 (11.1)
No
 587 (88.9)
Risk behavior (n = 554) <0.0001
Sexual 513 (92.6)
Injection drug user
 41 (7.4)
Sexual behavior (n = 566) 0.0004
Heterosexual 325 (57.4)
Homosexual or bisexual
 241 (42.6)
Highly active antiretroviral therapy‡ (n = 534) <0.0001
1998–2006 (free) 493 (92.3)
1993–1996 (not free)
 41 (7.7)
National web-based surveillance reporting and management system (n = 520) <0.0001
2002–2006 (available) 386 (74.2)
1998–2000 (not available)
 134 (25.8)
Outcome§ (n = 606) <0.0001
Survival 522 (86.1)
Death 84 (13.9)

*TB, tuberculosis.
†χ2 goodness-of-fit test with type I error = 0.05 used to examine differences in demographic, clinical, and behavioral characteristics.
‡Definition following World Health Organization guideline (1).
§Tracking for 1 year from report of TB diagnosis.

Main Article

References
  1. World Health Organization. Global tuberculosis control, 2008. Surveillance, planning, financing. Geneva: The Organization; 2008 [cited 24 Mar 2008]. Available from http://www.who.int/tb/publications/global_report/2008/download_centre/en/index.html
  2. Nunn  P, Williams  B, Floyd  K, Dye  C, Elzinga  G, Raviglione  M. Tuberculosis control in the era of HIV. Nat Rev Immunol. 2005;5:819–26. DOIPubMedGoogle Scholar
  3. Nunn  P, Brindle  R, Carpenter  L, Odhiambo  J, Wasunna  K, Newnham  R, Cohort study of human immunodeficiency virus infection in patients with tuberculosis in Nairobi, Kenya. Analysis of early (6-month) mortality. Am Rev Respir Dis. 1992;146:849–54.PubMedGoogle Scholar
  4. Kaplan  E, Meier  P. Non-parametric estimation from incomplete observation. J Am Stat Assoc. 1958;53:457–81. DOIGoogle Scholar
  5. Cox  DR, Oakes  D. Analysis of survival data. London: Chapman & Hall; 1984.
  6. Lim  HJ, Okwera  A, Mayanja-Kizza  H, Ellner  JJ, Mugerwa  RD, Whalen  CC. Effect of tuberculosis preventive therapy on HIV disease progression and survival in HIV-infected adults. HIV Clin Trials. 2006;7:172–83. DOIPubMedGoogle Scholar
  7. Muga  R, Ferreros  I, Langohr  K, de Olalla  PG, Del Romero  J, Quintana  M, Changes in the incidence of tuberculosis in a cohort of HIV-seroconverters before and after the introduction of HAART. AIDS. 2007;21:2521–7.PubMedGoogle Scholar
  8. Girardi  E, Sabin  CA, d'Arminio Monforte  A, Hogg  B, Phillips  AN, Gill  MJ, Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America. Clin Infect Dis. 2005;41:1772–82. DOIPubMedGoogle Scholar
  9. Girardi  E, Palmieri  F, Cingolani  A, Ammassari  A, Petrosillo  N, Gillini  L, Changing clinical presentation and survival in HIV-associated tuberculosis after highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2001;26:326–31.PubMedGoogle Scholar
  10. Lew  WJ, Lee  EG, Bai  JY, Kim  HJ, Bai  GH, Ahn  DI, An Internet-based surveillance system for tuberculosis in Korea. Int J Tuberc Lung Dis. 2006;10:1241–7.PubMedGoogle Scholar
  11. Snodgrass  I, Chew  SK. A national computer-based surveillance system for tuberculosis notification in Singapore. Tuber Lung Dis. 1995;76:264–70. DOIPubMedGoogle Scholar
  12. Chew  SK, Snodgrass  I. A computer-based surveillance system for human immunodeficiency virus infection in Singapore. Singapore Med J. 1995;36:147–51.PubMedGoogle Scholar
  13. Lenglet  A, Hernandez Pezzi  G. Comparison of the European Union Disease Surveillance Networks' websites. Euro Surveill. 2006;11:119–22.PubMedGoogle Scholar
  14. Rolfhamre  P, Janson  A, Arneborn  M, Ekdahl  K. SmiNet-2: Description of an internet-based surveillance system for communicable diseases in Sweden. Euro Surveill. 2006;11:103–7.PubMedGoogle Scholar

Main Article

Page created: December 08, 2010
Page updated: December 08, 2010
Page reviewed: December 08, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external